Lixisenatide

Definition: Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. source: Wikipedia

ID

708808004

ID date

29 Sep 2015

Previous ID

21890411000001108

Name

Lixisenatide